Sandy Tretbar
Group Leader Fraunhofer IZI
Dr. Sandy Tretbar is a molecular biologist and RNA biochemist whose research bridges RNA science and cell therapy in immuno-oncology. Her work focuses on mRNA-based gene therapy and the development of advanced therapy medicinal products (ATMPs) for the treatment of cancer and other diseases. By combining deep expertise in RNA biochemistry with translational applications in cell therapy, Dr. Tretbar is contributing to the advancement of next-generation therapeutic strategies.
Seminars
Wednesday 28th January 2026
Advancing mRNA-LNP Technology to Enable Safer and More Effective CAR Cell Therapies
11:00 am
- Explore how mRNA-LNP platforms enhance the precision and safety of CAR cell engineering
- Review preclinical advances demonstrating improved efficacy and reduced toxicity in CAR-based therapies
- Understand the translational potential of transient mRNA delivery to overcome current limitations in cell therapy
